title: The role of procalcitonin as predictor for neurological deficits after carotid endarterectomy.
abstract: OBJECTIVE
  Outcome of carotid endarterectomy (CEA) is defined by mortality rate as well as the neurological outcome due to cerebral ischemia. Thus the aim of this study was to evaluate the role of the acute phase protein procalcitonin (PCT) as a predictor for neurological deficits after carotid endarterectomy.
  
  
  METHODS
  Fifty-five patients with high grade stenosis of the internal carotid artery and interdisciplinary consensus for endarterectomy were followed. Neurological examination was performed before and after the procedure to analyze perioperative neurological deficits. Blood samples were obtained before and after CEA and procalcitonin was analyzed in 55 consecutive patients (65.5% symptomatic/34.5% asymptomatic).
  
  
  RESULTS
  No perioperative or in-hospital death was observed. Major complications did not occur, two patients suffered from bleeding requiring surgical intervention and one patient had a temporary peripheral facial nerve lesion. Postoperative neurological examination revealed no new deficit, there was no significant change of PCT (level pre- and post-CEA (the mean preoperative PCT was 0.25 ng/mL [SD 0.78, min 0.1, max 4.3]; the mean postoperative PCT was 0.11 ng/mL [SD 0.06, min 0.1, max 0.5]). There was no association found between perioperative neurological deficit and PCT.
  
  
  CONCLUSIONS
  The present study demonstrates that there is still not sufficient evidence to recommend PCT measurement as a predictor for perioperative neurological deficit during CEA.
authors.affiliation: European Vascular Center Aachen-Maastricht, Germany-The Netherlands. gmommertz@ukaachen.de
authors.forename: G
authors.initials: G
authors.lastname: MOMMERTZ
authors.forename: S
authors.initials: S
authors.lastname: LANGER
authors.forename: T
authors.initials: T
authors.lastname: KOEPPEL
authors.forename: J
authors.initials: J
authors.lastname: SCHIEFER
authors.forename: W H
authors.initials: WH
authors.lastname: MESS
authors.forename: M J
authors.initials: MJ
authors.lastname: JACOBS
authors.forename: M
authors.initials: M
authors.lastname: DAS
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D015415:Biomarkers / Q000097:blood; D002116:Calcitonin / Q000097:blood*; D015740:Calcitonin Gene-Related Peptide; D016893:Carotid Stenosis / Q000097:blood / Q000601:surgery*; D016894:Endarterectomy, Carotid / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009422:Nervous System Diseases / Q000097:blood / Q000209:etiology*; D009460:Neurologic Examination; D016017:Odds Ratio; D011237:Predictive Value of Tests; D011498:Protein Precursors / Q000097:blood*; D018570:Risk Assessment; D012720:Severity of Illness Index; D016896:Treatment Outcome
chemical_list: D015415:Biomarkers; C000606589:CALCA protein, human; D011498:Protein Precursors; D002116:Calcitonin; D015740:Calcitonin Gene-Related Peptide